Regenxbio Inc
F:RB0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regenxbio Inc
F:RB0
|
US |
|
Northern Minerals & Exploration Ltd
OTC:NMEX
|
US |
|
Phone Web SA
PAR:MLPHW
|
FR |
|
V
|
Vortex Metals Inc
F:DM8
|
CA |
|
Instabank ASA
F:93V
|
NO |
|
R
|
Repsol SA
SWB:REPA
|
ES |
|
Commander Resources Ltd
XTSX:CMD
|
CA |
|
Centaurus Energy Inc
F:72M0
|
CA |
|
Vantiva SA
PAR:VANTI
|
FR |
|
SecMark Consultancy Ltd
NSE:SECMARK
|
IN |
|
Fjordland Exploration Inc
XTSX:FEX
|
CA |
|
N
|
Norsk Solar AS
F:62L
|
NO |
|
X
|
Xtra Gold Resources Corp
OTC:XTGRF
|
BS |
|
H
|
Haisung TPC Co Ltd
KOSDAQ:059270
|
KR |
|
Fevertree Drinks PLC
F:FV8
|
UK |
|
O
|
OnCoCross Co Ltd
KOSDAQ:382150
|
KR |
|
Mill City Ventures III Ltd
NASDAQ:MCVT
|
US |
|
S
|
Sanok Rubber Company SA
F:1NX
|
PL |
|
Essential Metals Ltd
ASX:ESS
|
AU |
|
S
|
SpectraCure AB (publ)
STO:SPEC
|
SE |
|
L
|
Liberty Defense Holdings Ltd
OTC:LDDFF
|
CA |
|
STRATA Skin Sciences Inc
F:E2OM
|
US |
|
Lithium Chile Inc
F:KC3
|
CA |
Bankruptcy Probability
Regenxbio Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Regenxbio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Regenxbio Inc
NASDAQ:RGNX
|
681.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
440.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
224.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
64.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Regenxbio Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Regenxbio Inc has total debt of 154.7m USD. This includes both short-term (0 USD) and long-term (154.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
